Skip to main content

Table 1 Primary objective and outcome

From: Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trial

Objective

Outcome measure

Time point(s) of evaluation

To compare all-cause mortality of each regimen

Vital status (alive or dead)

14 days after randomisation

Back to article page

Trials

ISSN: 1745-6215